LW
LAURA WHITTON
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · WASHINGTON, DC · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
3
2 agencies contacted
Activity
filings by quarter
Works on
Specific issues
-S. 4504 / H.R 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes) -S. 1855 - Special Diabetes Program Reauthorization Act of 2023 -S. 1269 - INSULIN Act of 2023 -H.R 1499 - Affordable Insulin Now Act -S. 954 - Affordable Insulin Now Act of 2023 -H.R. 3800 - Chronic Disease Flexible Coverage Act -Issues related to cell and gene therapies
S. 4690 / H.R. 9027, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025 S. 4942 / H.R. 9029, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
H.R. 9029, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025.
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024. H.R. 4366 - Consolidated Appropriations Act of 2024. H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act. Issues pertaining to NIH appropriations for FY25.
Legislative outreach and monitoring related to insulin affordability. S. 1269 - INSULIN Act of 2023. S. 1855 - Special Diabetes Program Reauthorization Act of 2023.